US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HORIZON KINETICS MEDICAL ETF

37.87

+0.41311.10%

Volume:1K

Turnover:51.29K

Market Cap:17.79M

PE:- -

High:37.87

Open:37.33

Low:37.33

Close:37.45

52wk High:37.90

52wk Low:28.32

Shares:469.95K

Float Shares:469.95K

Volume Ratio:1.17

T/O Rate:0.29%

Dividend:0.41

Dividend Rate:1.08%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

US FDA Expands Approval for J&J's Drug for Rare Blood Disorder

FDA Approves J&J Imaavy for Warm Autoimmune Hemolytic Anemia Treatment

Alkermes’ Alixorexton Posts Positive Phase 2 Vibrance-1 Results in Narcolepsy Type 1 Study

The Lancet Neurology Publishes Data from Alkermes’ Positive Vibrance-1 Phase 2 Study of Alixorexton in Adults with Narcolepsy Type 1

THOMSON REUTERS

FDA Approves Imaavy® as First-Ever Treatment for Warm Autoimmune Hemolytic Anemia (Waiha), Representing a Landmark Advancement for Patients

THOMSON REUTERS

Savara announces presentations of Results from Phase 3 trial of Molgramostim

Oruka Therapeutics Names Todd Edwards Chief Commercial Officer

Eli Lilly Stock (LLY) in Focus as Hedge Fund Titan Ken Griffin Quadruples Position

Sector Update: Healthcare

MT Newswires Live

Eli Lilly’s New Obesity Drug LY3549492 Moves Forward With Completed Phase 1 Trial

Is AbbVie (ABBV) Fairly Valued As New Lung Cancer Data Impresses?

Simply Wall St.

Eli Lilly (LLY) On Foundayo Launch And Higher Outlook Faces A Rich Valuation

Simply Wall St.

Renalytix Discloses Director’s Link to Trellus Administration as KidneyIntelX Rollout Advances

Innovative Drugs Suddenly Lose Steam: What's Behind the Pullback? Chinese Fund Flags Technical Support Breach as CXO Leaders Slump, Yet Q4 Outlook for Healthcare Stays Bullish

Roche, Eli Lilly's Alzheimer's Blood Test Gets FDA Clearance

ANI Pharma Appoints Henry Gosebruch to Board of Directors

Drug Innovation and Computing Hardware Supply Chains Plunge, ChiNext Index Falls Over 3% | 3A Daily Report (August 24, 2026)

Barclays Sticks to Its Buy Rating for Eli Lilly & Co (LLY)

Hong Kong Biotech ETF Offers Full-Chain Access as Drug Developers and CXO Partners Enter Harvest Season

Ribomic Completes Site Network for Phase 3 Achondroplasia Trial in Japan

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/MEDX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MEDX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","market":"US","secType":"STK","nameCN":"HORIZON KINETICS MEDICAL ETF","latestPrice":37.865,"timestamp":1787677108140,"preClose":37.4519,"halted":0,"volume":1364,"delay":0,"changeRate":0.011030148003172069,"floatShares":469946,"shares":469946,"eps":0,"marketStatus":"Trading","change":0.4131,"latestTime":"08-25 13:01:39 EDT","open":37.33,"high":37.865,"low":37.33,"amount":51292.879,"amplitude":0.014285,"askPrice":37.98,"askSize":700,"bidPrice":37.74,"bidSize":700,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787688000000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":37.4519,"sharesOutstanding":569946,"nav":37.45,"aum":17599477.7,"dividendRate":0.01078,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":38.22,"preClose":37.4519,"latestTime":"07:47 EDT","volume":2,"amount":76.44,"timestamp":1787658475580,"change":0.7681,"changeRate":0.020509,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":37.36,"preClose":37.4519,"latestTime":"16:10 EDT","volume":6,"amount":224.7114,"timestamp":1787602204802,"change":-0.0919,"changeRate":-0.002454,"amplitude":0},"volumeRatio":1.171122},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","floatShares":469946,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.171122,"shares":469946,"dividePrice":0.4082,"high":37.865,"amplitude":0.014285,"preClose":37.4519,"low":37.33,"week52Low":28.3217,"pbRate":"--","week52High":37.9,"institutionHeld":0,"latestPrice":37.865,"eps":0,"divideRate":0.01078,"volume":1364,"delay":0,"ttmEps":0,"open":37.33,"prevYearClose":33.2024,"prevWeekClose":37.545,"prevMonthClose":34.9202,"prevQuarterClose":36.7138,"fiveDayClose":36.4884,"twentyDayClose":36.0292,"sixtyDayClose":34.3034},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MEDX\",params:#limit:5,,,undefined,":[{"date":"2025-12-23","symbol":"MEDX","amount":0.4088,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-24"},{"date":"2024-12-24","symbol":"MEDX","amount":0.502335,"announcedDate":"2024-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-24","defaultRemindTime":1735050600000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-24","currency":"USD","dateTimestamp":1735016400000,"payDate":"2024-12-26"},{"date":"2023-12-27","symbol":"MEDX","amount":1.379798,"announcedDate":"2023-12-26","type":"dividend","market":"US","newRecordDate":"2023-12-28","defaultRemindTime":1703687400000,"name":"HORIZON KINETICS MEDICAL ETF","recordDate":"2023-12-29","payableDate":"2023-12-28","currency":"USD","dateTimestamp":1703653200000,"payDate":"2023-12-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MEDX\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-27","recordDate":"2023-12-28","paymentDate":"2023-12-29","value":1.379798,"currency":"USD"},{"executeDate":"2024-12-24","recordDate":"2024-12-24","paymentDate":"2024-12-26","value":0.502335,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-24","value":0.4088,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MEDX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MEDX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662320194","title":"US FDA Expands Approval for J&J's Drug for Rare Blood Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2662320194","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662320194?lang=en_us&edition=fundamental","pubTime":"2026-08-25 06:32","pubTimestamp":1787610721,"startTime":"0","endTime":"0","summary":"US FDA expands approval for J&J's drug for rare blood disorderAug 24 (Reuters)-The U.S. Food and Drug Administration has approved the expanded use of Johnson & Johnson'sJNJ.Ndrug to treat a rare blood disorder, the company said on Monday.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL4N44L1IK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1145028129.USD","IE00BLSP4239.USD","LU0985320562.USD","LU1551013342.USD","IE00BJT1NW94.SGD","IE00BZ1G4Q59.USD","LU0098860793.USD","LU1935042991.SGD","IE00BDGV0183.EUR","FHLC","PJP","RXL","IE00BSNM7G36.USD","IHE","LU2089984988.USD","IE00BKVL7J92.USD","XLV","LU2129689514.USD","BK4504","LU1732799900.SGD","LU1989771016.USD","LU1585245621.USD","LU1894683264.USD","IXJ","LU2236285917.USD","BK4550","IE0002270589.USD","SGXZ80539844.SGD","LU2756315664.SGD","SG9999001176.SGD","GDOC","LU1196500208.SGD","LU2468319806.SGD","LU1244550577.SGD","JNJ","BMED","LU2430703095.HKD","MEDX","IYH","LU0787776722.HKD","IE00B3T34201.USD","TRUH","LU0345770993.USD","IE00BN8TJ469.HKD","LU0124676726.USD","VHT","IE00B7SZLL34.SGD","FTXH","JDOC","LU2456880835.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662913201","title":"FDA Approves J&J Imaavy for Warm Autoimmune Hemolytic Anemia Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2662913201","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662913201?lang=en_us&edition=fundamental","pubTime":"2026-08-25 06:31","pubTimestamp":1787610683,"startTime":"0","endTime":"0","summary":"FDA approves J&J IMAAVY for warm autoimmune hemolytic anemia treatmentFDA cleared IMAAVY  for warm autoimmune hemolytic anemia in patients aged 12+ who are current or prior corticosteroid users.Decision makes IMAAVY the first treatment specifically proven safe and effective for wAIHA, based on the Phase 2/3 ENERGY trial.Trial data showed a mean hemoglobin increase of 1 g/dL at Week 1, with improved FACIT-Fatigue scores at Week 24.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Johnson & Johnson published the original content used to generate this news brief on August 24, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL9KyWks:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1732799900.SGD","LU2129689605.HKD","FTXH","LU2602419157.SGD","IHE","IYH","LU1221951129.SGD","JDOC","RXL","LU1059921491.USD","MEDX","SGXZ80539844.SGD","LU0689626769.HKD","BMED","LU0792757196.USD","BK4504","LU2129689514.USD","LU2505996509.AUD","LU2430703251.USD","LU0545562505.USD","LU2471134796.USD","IE0034235303.USD","LU0820561909.HKD","LU1244550494.USD","LU1585245621.USD","LU0124676726.USD","LU0795875086.SGD","LU2347655156.SGD","SG9999001440.SGD","IE0002270589.USD","GDOC","PJP","IE000SO60NU8.SGD","LU1032466523.USD","JNJ","LU1066051225.USD","XLV","IE00BFXG1179.USD","LU1674673428.USD","IE00B3PB1722.GBP","FHLC","TRUH","SGXZ57979304.SGD","IXJ","VHT","IE00BVYPNW00.USD","LU0640476718.USD","LU0234572021.USD","LU0683600562.USD","LU2133065610.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662620199","title":"Alkermes’ Alixorexton Posts Positive Phase 2 Vibrance-1 Results in Narcolepsy Type 1 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2662620199","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662620199?lang=en_us&edition=fundamental","pubTime":"2026-08-25 06:30","pubTimestamp":1787610625,"startTime":"0","endTime":"0","summary":"Alkermes’ alixorexton posts positive Phase 2 Vibrance-1 results in narcolepsy type 1 studyAlkermes reported publication of positive Phase 2 Vibrance-1 results for alixorexton in adults with narcolepsy type 1 in The Lancet Neurology.Results were previously announced, not newly presented, showing improved daytime wakefulness and sleepiness measures versus placebo.Study also indicated reduced cataplexy at one dose, with broader patient-reported benefits in daily functioning.Safety profile appeared generally well tolerated, with mostly mild-to-moderate adverse events and no serious treatment-emergent events reported.Positive Phase 2 readouts supported the launch of the global Phase 3 Brilliance program testing once-daily and split-dose regimens in narcolepsy types 1 and 2.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purpos","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL56tjq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSIL","BK4139","IBRN","PSCH","ALKS","FBT","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662201993","title":"The Lancet Neurology Publishes Data from Alkermes’ Positive Vibrance-1 Phase 2 Study of Alixorexton in Adults with Narcolepsy Type 1","url":"https://stock-news.laohu8.com/highlight/detail?id=2662201993","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662201993?lang=en_us&edition=fundamental","pubTime":"2026-08-25 06:30","pubTimestamp":1787610600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUA7VQ936:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSIL","BK4139","MEDX","ALKS","IBRN","FBT","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662016052","title":"FDA Approves Imaavy® as First-Ever Treatment for Warm Autoimmune Hemolytic Anemia (Waiha), Representing a Landmark Advancement for Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2662016052","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662016052?lang=en_us&edition=fundamental","pubTime":"2026-08-25 06:29","pubTimestamp":1787610556,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nFWN44L0LI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0640476718.USD","BMED","IE00B19Z3B42.SGD","LU0122379950.USD","LU1261432733.SGD","LU2487616109.SGD","IE000BZT7R73.USD","IE00B42XCP33.USD","LU2430703178.SGD","MEDX","LU1228905540.USD","SG9999002224.SGD","LU1162221912.USD","LU1043141396.HKD","IHE","SG9999002232.USD","LU0070217475.USD","LU2347655156.SGD","IXJ","JNJ","LU0114720955.EUR","BK4532","IE00BDGV0183.EUR","LU0345769128.USD","FHLC","LU1244550221.USD","LU0466842654.USD","LU1061106388.HKD","IYH","GDOC","FTXH","SGXZ57979304.SGD","LU1506573853.SGD","VHT","JDOC","LU0345769631.USD","LU1280957306.USD","TRUH","XLV","IE0034235303.USD","PJP","LU2756315664.SGD","IE0002270589.USD","LU0964807845.USD","LU0889566641.SGD","RXL","LU1221951046.USD","LU0426417589.USD","LU0124676726.USD","LU2129689514.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662206573","title":"Savara  announces presentations of Results from Phase 3 trial of Molgramostim","url":"https://stock-news.laohu8.com/highlight/detail?id=2662206573","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662206573?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:10","pubTimestamp":1787602218,"startTime":"0","endTime":"0","summary":"Savara (SVRA) announced the acceptance of one oral presentation and two poster presentations on data from the Phase 3 IMPALA-2 clinical trial at th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/savara-announces-presentations-of-results-from-phase-3-trial-of-molgramostim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/savara-announces-presentations-of-results-from-phase-3-trial-of-molgramostim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","BK4139","NVIB","BBC","GDOC","PSIL","SVRA","MEDX","HYLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662205703","title":"Oruka Therapeutics Names Todd Edwards Chief Commercial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2662205703","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662205703?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:01","pubTimestamp":1787601676,"startTime":"0","endTime":"0","summary":"Oruka Therapeutics names Todd Edwards chief commercial officerOruka Therapeutics named Todd Edwards chief commercial officer, effective Aug. 24, 2026.Edwards joins from Arcutis Biotherapeutics, where ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL6VDQwY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1291159041.SGD","IDNA","INCY","LU0098860793.USD","LU0965508806.USD","LU2210150020.SGD","LU0820561909.HKD","LU1057294990.SGD","TRUH","LU1496350502.SGD","LU0211327993.USD","IE00B2B36J28.USD","IYH","RXL","FHLC","ARQT","LU2210149790.SGD","BCDF","LU2125909247.SGD","LU0395794307.EUR","LU1718418525.SGD","LU2347655156.SGD","PPH","JDOC","LU2357627491.SGD","IXJ","VHT","SG9999015945.SGD","IE00BN0W2W23.USD","IE00B3PB1722.GBP","LU1934455277.USD","FTXH","LU2129689431.USD","BK4550","LU0689626769.HKD","LU1923622614.USD","LU0124676726.USD","NDAQ","GLAM","LU0456855351.SGD","XLV","LU0738911758.USD","LU1551013342.USD","SG9999014021.USD","AGNG","MEDX","PJP","ORKA","ABBV","LU0949170772.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662051842","title":"Eli Lilly Stock (LLY) in Focus as Hedge Fund Titan Ken Griffin Quadruples Position","url":"https://stock-news.laohu8.com/highlight/detail?id=2662051842","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662051842?lang=en_us&edition=fundamental","pubTime":"2026-08-25 03:35","pubTimestamp":1787600104,"startTime":"0","endTime":"0","summary":"Eli Lilly’s ($LLY) stock is garnering attention on reports that hedge fund titan Ken Griffin nearly quadrupled his stake in the pharmaceutical comp...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/eli-lilly-stock-lly-in-focus-as-hedge-fund-titan-ken-griffin-quadruples-position?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/eli-lilly-stock-lly-in-focus-as-hedge-fund-titan-ken-griffin-quadruples-position?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4533","IE00BK4W5M84.HKD","IE00B4R5TH58.HKD","LU0225283273.USD","LU0289739699.SGD","THNR","IE00B7KXQ091.USD","LU0820561909.HKD","SG9999013999.USD","SG9999015986.USD","LU0385154629.USD","LU0820561818.USD","IE00BJT1NW94.SGD","MEDX","LU2028103732.USD","IE00BKPKM429.USD","LU2462157665.USD","IE00B4JS1V06.HKD","BK4007","LU1917777945.USD","TRUH","ELIS","LU0256863902.USD","SG9999015978.USD","LU0683600562.USD","LU0882574139.USD","IE00BFSS8Q28.SGD","SG9999014898.SGD","LU1064131342.USD","CANC","LU1804176565.USD","LU0174119429.USD","IE00BFTCPJ56.SGD","LU2168564495.EUR","LU0689472784.USD","LU1023059063.AUD","BK4581","IE0005OL40V9.USD","MHIP","LU2106854487.HKD","BK4599","LU0708995401.HKD","LU2361044865.SGD","IE00BWXC8680.SGD","IE00BN29S564.USD","ILDR","LU0345770993.USD","LU2111349929.HKD","LU0456855351.SGD","LU0133085943.USD","LU0889565916.HKD","LU0323591593.USD","LU1712237335.SGD","LU2264538146.SGD","SG9999014906.USD","LU2168564149.EUR","LU0006306889.USD","LU0672654240.SGD","LU0079474960.USD","IE0004445015.USD","LU0097036916.USD","LU1720051108.HKD","IYH","LU2168564065.EUR","LU0106261372.USD","VHT","LU1629891620.HKD","HRTS","IE00B2B36J28.USD","IE00BJLML261.HKD","ELIL","FTXH","IE00BJJMRY28.SGD","LU0943347566.SGD","LU0316494557.USD","LU1691799644.USD","LU2168564222.USD","LU1057294990.SGD","JDOC","BK4588","LU0061475181.USD","SGXZ81514606.USD","IE0001KFT4U8.USD","LU2471134796.USD","XLV","LU2750360641.GBP","LU1979441026.SGD","LU1267930730.SGD","LU2023250330.USD","LU0354030511.USD","LU2324357040.USD","SG9999015952.SGD","SG9999015945.SGD","LU2112291526.USD","SG9999017495.SGD","LU0882574055.USD","LU2271345857.HKD","LU1868836914.USD","LU2213496289.HKD","LU0158827948.USD","LU1069344957.HKD","LU0417517546.SGD","LU1983299246.USD","IE00BFSS7M15.SGD","LU0256863811.USD","IE00BJJMRX11.SGD","LU0820562030.AUD","LU1720051017.SGD","LU2087625088.SGD","LU2491049909.HKD","LU2756315318.SGD","SGXZ99366536.SGD","LLYZ","LU0210536198.USD","LU2265009873.SGD","LU2023251221.USD","LU2896262040.SGD","LU1093756168.USD","LU1868836591.USD","LU2491050154.USD","LU2237443549.SGD","SG9999001176.SGD","IE00B1BXHZ80.USD","LU2756315664.SGD","LU0096364046.USD","IE0004445239.USD","BK4585","LU1814569148.SGD","GB00BDT5M118.USD","IXJ","WDNA","LU0198837287.USD","LU2108987350.USD","LU0122379950.USD","LU2063271972.USD","BK4516","LLII","LU2089284900.SGD","IE0009355771.USD","LLY","LU0109394709.USD","LU2237443978.SGD","LU2552382132.HKD","LU2746668461.USD","LU1061106388.HKD","SGXZ57979304.SGD","LU2168563687.JPY","LU2746668974.SGD","LU2361045086.USD","LU0094547139.USD","LU2089283258.USD","LU1974910355.USD","LU2211815571.USD","LU0114720955.EUR","LLYX","LU1232071149.USD","LU2237438978.USD","LU0158827781.USD","LU1989771016.USD","OZEM","BK4534","LU1551013342.USD","LU1988902786.USD","LU0466842654.USD","MEDI","LU1280957306.USD","LU1323610961.USD","LU1366192091.USD","IE00BJJMRZ35.SGD","LU2237443382.USD","LU2602419157.SGD","GDOC","SG9999018857.SGD","FHLC","LU2237443622.USD","PPH","LU1868836757.USD","LU2456880835.USD","LU0823434740.USD","SG9999014914.USD","TMED","IE00B1XK9C88.USD","LU0471298777.SGD","LU2462591350.SGD","LU1548497426.USD","IE00BKDWB100.SGD","CURE","LU2750360997.AUD","PJP","LU0823434583.USD","LU0471298694.HKD","LU0786609619.USD","LU0353189763.USD","LU2089984988.USD","LU0266013472.USD","LU1145028129.USD","LU2471134523.USD","IE00BK4W5L77.USD","LU1127390331.HKD","LU2237443465.HKD","RXL","LU0787776722.HKD","LU1035775433.USD","LU2491050071.SGD","LU2237443895.HKD","LU0823416689.USD","SG9999001176.USD","LU2361044949.HKD","LU2552382058.USD","LU0354030438.USD","LU0203201768.USD","LU2468319806.SGD","LU0353189680.USD","LU2360106947.USD","LU2552382215.SGD","LU0058720904.USD","LU0640476718.USD","SGXZ51526630.SGD","LU2236285917.USD","SGXZ31699556.SGD","LU2471134952.CNY","IHE","LU1551013425.SGD","LU2417539215.USD","SG9999014880.SGD","LU1868837300.USD","LU2461242641.AUD","LU0109391861.USD","LU0320765992.SGD","LU0234572021.USD","LU1623119135.USD","LU0964807845.USD","AGNG","IE0002141913.USD","LU1093756325.SGD","LU2357305700.SGD","LU2471134879.HKD","LU0345770308.USD","SG9999018865.SGD","LU1868837136.USD","LU2023250504.SGD","LU0320765059.SGD","LU1291159041.SGD","LU0432979614.USD","LU0203202063.USD","IE00B775H168.HKD","LU0238689110.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662208903","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2662208903","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662208903?lang=en_us&edition=fundamental","pubTime":"2026-08-25 01:21","pubTimestamp":1787592076,"startTime":"0","endTime":"0","summary":"Healthcare stocks were softer Monday afternoon, with the NYSE Healthcare Index down 0.2% and the State Street Health Care Select Sector SPDR ETF  fractionally lower.The iShares Biotechnology ETF  shed 0.7%.In corporate news, Eli Lilly  has launched its Foundayo weight-loss pill in the UK, making Britain the first European country where the oral treatment is available, news outlets reported Monday, citing a company statement. Lilly shares were down 0.6%.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2089284900.SGD","LU0320765992.SGD","LU2237443465.HKD","BK4007","LU1064131342.USD","LU2112291526.USD","LU0787776722.HKD","BK4588","LU1868836914.USD","PPH","IE00BFSS8Q28.SGD","LU0320765059.SGD","LU0823416689.USD","MEDX","LU0094547139.USD","LU2417539215.USD","SG9999015986.USD","LU2552382132.HKD","LU1551013342.USD","LU2063271972.USD","LU2456880835.USD","LU0061475181.USD","LU1868837136.USD","LU0640476718.USD","LU1280957306.USD","SG9999001176.USD","LU0198837287.USD","THNR","ELIS","SG9999014898.SGD","LU0289739699.SGD","LU2237443382.USD","IE00B2B36J28.USD","IE00BJJMRX11.SGD","LU2324357040.USD","LU0456855351.SGD","SGXZ57979304.SGD","LU2271345857.HKD","SGXZ99366536.SGD","BK4581","LU2471134523.USD","OZEM","LU1868836757.USD","LU0133085943.USD","LU2471134879.HKD","SG9999018865.SGD","LU2756315664.SGD","LU2089283258.USD","LU2491050071.SGD","XLV","LU2468319806.SGD","LU0109391861.USD","IE0002141913.USD","BK4516","LU0203202063.USD","IYH","LU1804176565.USD","LLY","IE00B7KXQ091.USD","LU0385154629.USD","LU1868836591.USD","LU1988902786.USD","LU2237443895.HKD","LU2746668461.USD","LU0203201768.USD","MHIP","LU0097036916.USD","LU2357305700.SGD","LU0882574055.USD","SG9999014914.USD","LU0943347566.SGD","LU0238689110.USD","LU1291159041.SGD","LU2023251221.USD","IBB","LU0158827948.USD","LU1917777945.USD","LU2552382058.USD","LU0823434740.USD","LU2213496289.HKD","LLII","LU1814569148.SGD","LU1145028129.USD","LU1720051108.HKD","SG9999017495.SGD","LU0820561909.HKD","TMED","IE00BN29S564.USD","HRTS","BK4533","LU0354030511.USD","LU0786609619.USD","LU2237438978.USD","IE00BFTCPJ56.SGD","LU2746668974.SGD","LU0823434583.USD","IE00BJJMRZ35.SGD","LU2237443549.SGD","LU2361045086.USD","LU0353189763.USD","LU0354030438.USD","LU0471298694.HKD","SGXZ31699556.SGD","SG9999015952.SGD","LU2491049909.HKD","IE00BJLML261.HKD","LU0210536198.USD","LU2750360641.GBP","LU1093756325.SGD","IE00BFSS7M15.SGD","IE00B4JS1V06.HKD","LU2471134796.USD","LU1974910355.USD","JDOC","IE00BWXC8680.SGD","IE00BK4W5L77.USD","SG9999001176.SGD","LU0689472784.USD","LU2211815571.USD","IE0001KFT4U8.USD","LU0820561818.USD","LU0096364046.USD","LU1127390331.HKD","IHE","LU2462157665.USD","LU0114720955.EUR","LU0466842654.USD","LU0158827781.USD","LU0316494557.USD","LU0225283273.USD","LU2106854487.HKD","IE00B775H168.HKD","LU0471298777.SGD","LU0417517546.SGD","ILDR","RXL","IE00BJT1NW94.SGD","LU1720051017.SGD","LU1057294990.SGD","LABU","LU0708995401.HKD","LU2602419157.SGD","LU2264538146.SGD","LU1061106388.HKD","LU2361044949.HKD","SG9999014906.USD","LU2168563687.JPY","LU2471134952.CNY","GDOC","LU0109394709.USD","LU2089984988.USD","LU2023250504.SGD","FHLC","LU2108987350.USD","BK4534","IE00B1BXHZ80.USD","LU0353189680.USD","LU2237443978.SGD","LU2028103732.USD","LU1548497426.USD","LU2023250330.USD","LU1983299246.USD","LU0820562030.AUD","LU2750360997.AUD","FTXH","IXJ","LU0122379950.USD","LU2237443622.USD","LU2552382215.SGD","LU0234572021.USD","TRUH","IE00BKDWB100.SGD","IE0004445239.USD","LLYX","LU0323591593.USD","LU0345770308.USD","LU1691799644.USD","LU1868837300.USD","LU2361044865.SGD","LU2896262040.SGD","IE0004445015.USD","MEDI","LU2265009873.SGD","SG9999015978.USD","IE00BJJMRY28.SGD","SG9999018857.SGD","BK4599","LU1323610961.USD","LU2168564495.EUR","LU0672654240.SGD","LU0174119429.USD","LU0006306889.USD","LU1232071149.USD","LU1629891620.HKD","LU1989771016.USD","BK4585","LU2168564065.EUR","PJP","SGXZ51526630.SGD","LU0432979614.USD","LU1712237335.SGD","LU2491050154.USD","LLYZ","LU0079474960.USD","LU2168564149.EUR","LU1623119135.USD","LU1069344957.HKD","LU0266013472.USD","SGXZ81514606.USD","IE0005OL40V9.USD","SG9999013999.USD","SG9999015945.SGD","IE00BKPKM429.USD","LU0889565916.HKD","CURE","XBI","IE0009355771.USD","GB00BDT5M118.USD","LU2111349929.HKD","LU0683600562.USD","LU2360106947.USD","LU1267930730.SGD","LU0106261372.USD","LU2087625088.SGD","CANC","AGNG","LU1551013425.SGD","LU2756315318.SGD","LU1035775433.USD","LU2236285917.USD","LU0964807845.USD","VHT","LU1093756168.USD","LU2168564222.USD","IE00B4R5TH58.HKD","LU0256863902.USD","LU1979441026.SGD","IE00B1XK9C88.USD","LU0256863811.USD","LU0058720904.USD","LU0345770993.USD","LU1023059063.AUD","LU2461242641.AUD","LU2462591350.SGD","ELIL","LU0882574139.USD","IE00BK4W5M84.HKD","LU1366192091.USD","SG9999014880.SGD","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662270749","title":"Eli Lilly’s New Obesity Drug LY3549492 Moves Forward With Completed Phase 1 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2662270749","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662270749?lang=en_us&edition=fundamental","pubTime":"2026-08-25 00:30","pubTimestamp":1787589016,"startTime":"0","endTime":"0","summary":"Eli Lilly And Company ($LLY) announced an update on their ongoing clinical study. The Phase 1 study, officially titled “A Phase-1, Parallel-Design,...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/eli-lillys-new-obesity-drug-ly3549492-moves-forward-with-completed-phase-1-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/eli-lillys-new-obesity-drug-ly3549492-moves-forward-with-completed-phase-1-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0225283273.USD","LU1868836591.USD","LU0466842654.USD","LU2063271972.USD","LU2746668974.SGD","SG9999017495.SGD","LU2168564149.EUR","PPH","LU2089284900.SGD","LU0323591593.USD","LU2271345857.HKD","LU0823434583.USD","LU1035775433.USD","LU1868836914.USD","SGXZ81514606.USD","LU0672654240.SGD","LU2750360997.AUD","IE00B775H168.HKD","BK4588","LU0133085943.USD","IHE","LU1979441026.SGD","LU2491049909.HKD","BK4533","LU0640476718.USD","LU2023250330.USD","LU0234572021.USD","BK4599","LU1868836757.USD","LU0471298777.SGD","LU1127390331.HKD","LU2023251221.USD","LU0061475181.USD","LU0079474960.USD","LU2112291526.USD","IE0001KFT4U8.USD","BK4581","LU0786609619.USD","LU2028103732.USD","ELIL","LU0058720904.USD","LU0158827948.USD","LU0210536198.USD","LU2471134796.USD","BK4585","IE00BKDWB100.SGD","LU2361045086.USD","LU0320765059.SGD","LU2265009873.SGD","GB00BDT5M118.USD","LU0354030511.USD","LU0203202063.USD","LU0114720955.EUR","LU1267930730.SGD","LU1712237335.SGD","ELIS","RXL","LLYX","LU2237443465.HKD","SG9999015945.SGD","IE0009355771.USD","LU2468319806.SGD","LU0385154629.USD","LU1548497426.USD","IXJ","LU0683600562.USD","LU2750360641.GBP","SG9999015952.SGD","FTXH","LU1064131342.USD","LU1551013425.SGD","IE00BK4W5M84.HKD","LLY","LU0823416689.USD","IE00BK4W5L77.USD","LU0289739699.SGD","LU1989771016.USD","LU2417539215.USD","LU0787776722.HKD","LU0943347566.SGD","LU1057294990.SGD","IE00BFSS8Q28.SGD","WDNA","LU1291159041.SGD","LU2552382132.HKD","LU1623119135.USD","LU0109391861.USD","LU1366192091.USD","SGXZ99366536.SGD","IE00B1BXHZ80.USD","SG9999018865.SGD","MHIP","MEDX","LU0109394709.USD","LU0353189680.USD","SG9999015986.USD","LU0820562030.AUD","LU2236285917.USD","ILDR","LU0106261372.USD","LU0820561818.USD","LU0354030438.USD","LU0882574139.USD","LU1720051108.HKD","LU1720051017.SGD","LU2089984988.USD","LU2491050154.USD","LU2756315664.SGD","XLV","GDOC","LU0345770993.USD","IE00B7KXQ091.USD","IE00BFTCPJ56.SGD","IE00BWXC8680.SGD","LU2111349929.HKD","LU2471134523.USD","LU2471134879.HKD","LU2237443382.USD","VHT","LU1974910355.USD","BK4534","LU1983299246.USD","LU2746668461.USD","SGXZ31699556.SGD","FHLC","LU0097036916.USD","LU1917777945.USD","LU0158827781.USD","LU2471134952.CNY","LU2896262040.SGD","AGNG","LU0689472784.USD","SG9999014914.USD","SG9999014880.SGD","LU0353189763.USD","LU0820561909.HKD","LU0471298694.HKD","LU1145028129.USD","BK4007","CURE","LU2108987350.USD","LU2361044949.HKD","LU0096364046.USD","HRTS","IE0004445015.USD","IE00B4JS1V06.HKD","LU0198837287.USD","LU0708995401.HKD","LU1069344957.HKD","LU1232071149.USD","LU1023059063.AUD","LU0122379950.USD","LU0316494557.USD","LU2087625088.SGD","SGXZ51526630.SGD","LU2237438978.USD","LU2168564065.EUR","LU0174119429.USD","IE0002141913.USD","LU0320765992.SGD","LU1814569148.SGD","SG9999001176.USD","LLYZ","LU0266013472.USD","SG9999018857.SGD","IE00B2B36J28.USD","LU0456855351.SGD","LU2237443622.USD","SG9999001176.SGD","LU0094547139.USD","LU2168563687.JPY","JDOC","LU0345770308.USD","LU2106854487.HKD","LU2213496289.HKD","SG9999014906.USD","LU2360106947.USD","LU2552382058.USD","LU1551013342.USD","IE00B1XK9C88.USD","LU2264538146.SGD","TMED","BK4516","LU1868837300.USD","LU0417517546.SGD","SG9999013999.USD","LU2462157665.USD","SG9999014898.SGD","IE00BN29S564.USD","IE00BJJMRY28.SGD","LU0203201768.USD","LU0006306889.USD","LU2602419157.SGD","IE0005OL40V9.USD","LU2023250504.SGD","LU2089283258.USD","LU1061106388.HKD","THNR","IE00BJJMRX11.SGD","LU1093756168.USD","IE0004445239.USD","LU2168564222.USD","LU2237443978.SGD","LU2361044865.SGD","LU2462591350.SGD","LU2237443549.SGD","IYH","IE00BKPKM429.USD","LU1280957306.USD","PJP","LU0823434740.USD","LU2357305700.SGD","LU1988902786.USD","LU2456880835.USD","LU2211815571.USD","MEDI","IE00B4R5TH58.HKD","CANC","LU2237443895.HKD","SG9999015978.USD","IE00BFSS7M15.SGD","OZEM","LU0432979614.USD","LU2552382215.SGD","LU0256863902.USD","LU0238689110.USD","LU1804176565.USD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU1629891620.HKD","LU0882574055.USD","IE00BJLML261.HKD","LU1868837136.USD","TRUH","LLII","LU2491050071.SGD","LU1323610961.USD","LU2168564495.EUR","SGXZ57979304.SGD","LU0889565916.HKD","LU2461242641.AUD","LU0256863811.USD","LU0964807845.USD","LU1691799644.USD","LU1093756325.SGD","LU2324357040.USD","LU2756315318.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662208416","title":"Is AbbVie (ABBV) Fairly Valued As New Lung Cancer Data Impresses?","url":"https://stock-news.laohu8.com/highlight/detail?id=2662208416","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662208416?lang=en_us&edition=fundamental","pubTime":"2026-08-25 00:27","pubTimestamp":1787588879,"startTime":"0","endTime":"0","summary":"AbbVie (ABBV) is back in focus after new lung cancer data at the 2026 World Conference on Lung Cancer, where its investigational therapies in both NSCLC and SCLC reported high objective response rates with manageable safety profiles.\nSee our latest analysis for AbbVie.\nThe latest lung cancer data arrives during a strong run for AbbVie, with a 24.32% 90 day share price return and a 31.62% 1 year total shareholder return suggesting that momentum has been building.\nIf this lung cancer update has...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/141885706-main-header/1756256222285","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/141885706-main-header/1756256222285"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-abbv/abbvie/news/is-abbvie-abbv-fairly-valued-as-new-lung-cancer-data-impress","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-abbv/abbvie/news/is-abbvie-abbv-fairly-valued-as-new-lung-cancer-data-impress","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PPH","IE000BZT7R73.USD","LU1989772923.USD","LU0170899867.USD","LU1003077747.HKD","LU1496350502.SGD","LU1023059063.AUD","LU0726765562.USD","GLAM","LU0708994859.HKD","FHLC","SG9999015945.SGD","ABBV","LU0211328371.USD","LU0234572021.USD","LU1934455194.USD","LU1061106388.HKD","IE00B2B36J28.USD","LU0122379950.USD","JDOC","IE00B19Z3581.USD","LU1934455277.USD","LU0310799852.SGD","LU2112291526.USD","LU1934455863.HKD","LU2347655073.USD","RXL","LU1057294990.SGD","LU2237443978.SGD","LU2357627491.SGD","IE0002141913.USD","LU0861579265.USD","LU0128525929.USD","AGNG","TRUH","FTXH","IE00BBT3K403.USD","MEDX","LU0057025933.USD","LU0868494708.USD","IYH","LU0234570918.USD","IE00BFTCPJ56.SGD","PJP","LU2468319806.SGD","SG9999001440.SGD","VHT","BK4559","XLV","IXJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662208091","title":"Eli Lilly (LLY) On Foundayo Launch And Higher Outlook Faces A Rich Valuation","url":"https://stock-news.laohu8.com/highlight/detail?id=2662208091","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662208091?lang=en_us&edition=fundamental","pubTime":"2026-08-24 23:25","pubTimestamp":1787585159,"startTime":"0","endTime":"0","summary":"Eli Lilly (LLY) has moved further into obesity and diabetes care with the UK launch of its once daily oral GLP-1 pill Foundayo, orforglipron, shortly after lifting its full year outlook.\nSee our latest analysis for Eli Lilly.\nThe launch of Foundayo comes during a strong run for Eli Lilly’s stock, with a 90 day share price return of 17.91% and a 1 year total shareholder return of 81.69%. This indicates momentum that has built rather than faded over multiple years.\nIf you are interested in how...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/285467-main-header/1756214710679","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/285467-main-header/1756214710679"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-lly/eli-lilly/news/eli-lilly-lly-on-foundayo-launch-and-higher-outlook-faces-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-lly/eli-lilly/news/eli-lilly-lly-on-foundayo-launch-and-higher-outlook-faces-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4533","IE00BK4W5M84.HKD","IE00B4R5TH58.HKD","LU0225283273.USD","LU0289739699.SGD","THNR","IE00B7KXQ091.USD","LU0820561909.HKD","SG9999013999.USD","SG9999015986.USD","LU0385154629.USD","LU0820561818.USD","IE00BJT1NW94.SGD","MEDX","LU2028103732.USD","IE00BKPKM429.USD","LU2462157665.USD","IE00B4JS1V06.HKD","BK4007","LU1917777945.USD","TRUH","ELIS","LU0256863902.USD","SG9999015978.USD","LU0683600562.USD","LU0882574139.USD","IE00BFSS8Q28.SGD","SG9999014898.SGD","LU1064131342.USD","CANC","LU1804176565.USD","LU0174119429.USD","IE00BFTCPJ56.SGD","LU2168564495.EUR","LU0689472784.USD","LU1023059063.AUD","BK4581","IE0005OL40V9.USD","MHIP","LU2106854487.HKD","BK4599","LU0708995401.HKD","LU2361044865.SGD","IE00BWXC8680.SGD","IE00BN29S564.USD","ILDR","LU0345770993.USD","LU2111349929.HKD","LU0456855351.SGD","LU0133085943.USD","LU0889565916.HKD","LU0323591593.USD","LU1712237335.SGD","LU2264538146.SGD","SG9999014906.USD","LU2168564149.EUR","LU0006306889.USD","LU0672654240.SGD","LU0079474960.USD","IE0004445015.USD","LU0097036916.USD","LU1720051108.HKD","IYH","LU2168564065.EUR","LU0106261372.USD","VHT","LU1629891620.HKD","HRTS","IE00B2B36J28.USD","IE00BJLML261.HKD","ELIL","FTXH","IE00BJJMRY28.SGD","LU0943347566.SGD","LU0316494557.USD","LU1691799644.USD","LU2168564222.USD","LU1057294990.SGD","JDOC","BK4588","LU0061475181.USD","SGXZ81514606.USD","IE0001KFT4U8.USD","LU2471134796.USD","XLV","LU2750360641.GBP","LU1979441026.SGD","LU1267930730.SGD","LU2023250330.USD","LU0354030511.USD","LU2324357040.USD","SG9999015952.SGD","SG9999015945.SGD","LU2112291526.USD","SG9999017495.SGD","LU0882574055.USD","LU2271345857.HKD","LU1868836914.USD","LU2213496289.HKD","LU0158827948.USD","LU1069344957.HKD","LU0417517546.SGD","LU1983299246.USD","IE00BFSS7M15.SGD","LU0256863811.USD","IE00BJJMRX11.SGD","LU0820562030.AUD","LU1720051017.SGD","LU2087625088.SGD","LU2491049909.HKD","LU2756315318.SGD","SGXZ99366536.SGD","LLYZ","LU0210536198.USD","LU2265009873.SGD","LU2023251221.USD","LU2896262040.SGD","LU1093756168.USD","LU1868836591.USD","LU2491050154.USD","LU2237443549.SGD","SG9999001176.SGD","IE00B1BXHZ80.USD","LU2756315664.SGD","LU0096364046.USD","IE0004445239.USD","BK4585","LU1814569148.SGD","GB00BDT5M118.USD","IXJ","WDNA","LU0198837287.USD","LU2108987350.USD","LU0122379950.USD","LU2063271972.USD","BK4516","LLII","LU2089284900.SGD","IE0009355771.USD","LLY","LU0109394709.USD","LU2237443978.SGD","LU2552382132.HKD","LU2746668461.USD","LU1061106388.HKD","SGXZ57979304.SGD","LU2168563687.JPY","LU2746668974.SGD","LU2361045086.USD","LU0094547139.USD","LU2089283258.USD","LU1974910355.USD","LU2211815571.USD","LU0114720955.EUR","LLYX","LU1232071149.USD","LU2237438978.USD","LU0158827781.USD","LU1989771016.USD","OZEM","BK4534","LU1551013342.USD","LU1988902786.USD","LU0466842654.USD","MEDI","LU1280957306.USD","LU1323610961.USD","LU1366192091.USD","IE00BJJMRZ35.SGD","LU2237443382.USD","LU2602419157.SGD","GDOC","SG9999018857.SGD","FHLC","LU2237443622.USD","PPH","LU1868836757.USD","LU2456880835.USD","LU0823434740.USD","SG9999014914.USD","TMED","IE00B1XK9C88.USD","LU0471298777.SGD","LU2462591350.SGD","LU1548497426.USD","IE00BKDWB100.SGD","CURE","LU2750360997.AUD","PJP","LU0823434583.USD","LU0471298694.HKD","LU0786609619.USD","LU0353189763.USD","LU2089984988.USD","LU0266013472.USD","LU1145028129.USD","LU2471134523.USD","IE00BK4W5L77.USD","LU1127390331.HKD","LU2237443465.HKD","RXL","LU0787776722.HKD","LU1035775433.USD","LU2491050071.SGD","LU2237443895.HKD","LU0823416689.USD","SG9999001176.USD","LU2361044949.HKD","LU2552382058.USD","LU0354030438.USD","LU0203201768.USD","LU2468319806.SGD","LU0353189680.USD","LU2360106947.USD","LU2552382215.SGD","LU0058720904.USD","LU0640476718.USD","SGXZ51526630.SGD","LU2236285917.USD","SGXZ31699556.SGD","LU2471134952.CNY","IHE","LU1551013425.SGD","LU2417539215.USD","SG9999014880.SGD","LU1868837300.USD","LU2461242641.AUD","LU0109391861.USD","LU0320765992.SGD","LU0234572021.USD","LU1623119135.USD","LU0964807845.USD","AGNG","IE0002141913.USD","LU1093756325.SGD","LU2357305700.SGD","LU2471134879.HKD","LU0345770308.USD","SG9999018865.SGD","LU1868837136.USD","LU2023250504.SGD","LU0320765059.SGD","LU1291159041.SGD","LU0432979614.USD","LU0203202063.USD","IE00B775H168.HKD","LU0238689110.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661271017","title":"Renalytix Discloses Director’s Link to Trellus Administration as KidneyIntelX Rollout Advances","url":"https://stock-news.laohu8.com/highlight/detail?id=2661271017","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661271017?lang=en_us&edition=fundamental","pubTime":"2026-08-24 21:42","pubTimestamp":1787578963,"startTime":"0","endTime":"0","summary":"Renalytix ( ($GB:RENX) ) has issued an update. Renalytix plc, a London- and New York-based precision medicine diagnostics group, specializes in art...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/renalytix-discloses-directors-link-to-trellus-administration-as-kidneyintelx-rollout-advances?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/renalytix-discloses-directors-link-to-trellus-administration-as-kidneyintelx-rollout-advances?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNMX","WDNA","LFSC","TMAT","HTEC","FDIF","BK4585","IDNA","GNOM","XT","HELX","BMED","PBE","SYNB","BK4588","IBB","MEDX","JDOC","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163554203","title":"Innovative Drugs Suddenly Lose Steam: What's Behind the Pullback? Chinese Fund Flags Technical Support Breach as CXO Leaders Slump, Yet Q4 Outlook for Healthcare Stays Bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1163554203","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163554203?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:03","pubTimestamp":1787573000,"startTime":"0","endTime":"0","summary":"On August 24, Hong Kong stocks saw a deep correction, with the healthcare sector, which had been a recent hotspot, also moving lower. The Hong Kong Stock Connect innovative drug segment opened higher...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","159316","WX","BK1574","CXO","IBBQ","159938","BK1515","LNGR","BK1161","159992","09939","MEDX","FLHK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661427527","title":"Roche, Eli Lilly's Alzheimer's Blood Test Gets FDA Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=2661427527","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661427527?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:51","pubTimestamp":1787572278,"startTime":"0","endTime":"0","summary":"Roche, Eli Lilly's Alzheimer's blood test gets FDA clearanceAug 24 (Reuters)-The U.S. Food and Drug Administration has cleared RocheROPC.Sand partner Eli Lilly'sLLY.Nblood test to help identify signs ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL4N44L0T4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","LU1232071149.USD","LU1804176565.USD","LU2462591350.SGD","SG9999018857.SGD","SG9999001176.SGD","LU0823434740.USD","LU0320765992.SGD","LU1023059063.AUD","BK4007","LU1061106388.HKD","SG9999001176.USD","LU0823416689.USD","LU0158827948.USD","LU2237443382.USD","ELIL","SG9999014906.USD","LU1629891620.HKD","LU2361044949.HKD","THNR","LU2213496289.HKD","03165","MEDX","LU2264538146.SGD","LU2023250330.USD","LU2237443549.SGD","LU2456880835.USD","RXL","OZEM","LU0225283273.USD","LU2089284900.SGD","SG9999014914.USD","IE00BN29S564.USD","LLYX","LU1093756325.SGD","IE00BKPKM429.USD","LU0345770993.USD","LU1551013342.USD","LU2108987350.USD","BK4533","LU0786609619.USD","LU2360106947.USD","LU2211815571.USD","LU1989771016.USD","IE00B775H168.HKD","LU2063271972.USD","LU1069344957.HKD","LU2112291526.USD","SGXZ99366536.SGD","LU0353189680.USD","XLV","LU0266013472.USD","LU1548497426.USD","LU2746668974.SGD","LU1979441026.SGD","HRTS","TRUH","IE00B4JS1V06.HKD","RHHBY","LU0385154629.USD","LU2087625088.SGD","BK4581","IE00BK4W5L77.USD","LU1291159041.SGD","LU2168564222.USD","LU2324357040.USD","LU2491050154.USD","CURE","LU1983299246.USD","LU0683600562.USD","LLYZ","LU0198837287.USD","LU0234572021.USD","LU2168564065.EUR","LU0456855351.SGD","IE0005OL40V9.USD","LU1323610961.USD","SG9999013999.USD","LU2111349929.HKD","TMED","LU0432979614.USD","LU0094547139.USD","LU0058720904.USD","IE00BJLML261.HKD","CANC","LU1064131342.USD","LU2471134523.USD","WDNA","LU0689472784.USD","LU0133085943.USD","IHE","LLII","VHT","SG9999014880.SGD","ELIS","SG9999015978.USD","FHLC","LU0471298777.SGD","LU0203201768.USD","LU2602419157.SGD","LU0061475181.USD","IE00BJJMRZ35.SGD","LU0109394709.USD","LU1814569148.SGD","JDOC","LU2237443895.HKD","SG9999014898.SGD","LU2471134796.USD","FTXH","IE0004445239.USD","LU0820561909.HKD","LU2237443978.SGD","BK4599","LU1868837300.USD","LU0079474960.USD","LU2028103732.USD","PPH","LU1035775433.USD","AGNG","IE00B2B36J28.USD","SGXZ31699556.SGD","LU2746668461.USD","BK4516","LLY","SG9999017495.SGD","IYH","LU0640476718.USD","LU0122379950.USD","LU0471298694.HKD","LU2552382058.USD","LU2756315318.SGD","LU2089283258.USD","LU0320765059.SGD","LU0708995401.HKD","SGXZ81514606.USD","LU0158827781.USD","LU0106261372.USD","LU0114720955.EUR","LU1988902786.USD","LU2023251221.USD","LU2236285917.USD","LU0882574139.USD","LU1366192091.USD","BK4588","LU1868837136.USD","GB00BDT5M118.USD","LU0354030438.USD","LU1720051108.HKD","IE00BJJMRY28.SGD","LU0889565916.HKD","LU2089984988.USD","LU2750360641.GBP","LU1057294990.SGD","IXJ","LU2552382215.SGD","LU2237438978.USD","LU2462157665.USD","IE00BFSS8Q28.SGD","LU1712237335.SGD","LU2552382132.HKD","LU0238689110.USD","LU0820561818.USD","LU1868836914.USD","LU1093756168.USD","LU2756315664.SGD","LU1145028129.USD","LU2491049909.HKD","BK4534","LU0672654240.SGD","LU0109391861.USD","LU0345770308.USD","LU2237443622.USD","LU0943347566.SGD","LU2265009873.SGD","IE00BKDWB100.SGD","IE0009355771.USD","LU0316494557.USD","MHIP","LU1267930730.SGD","LU1127390331.HKD","LU1868836757.USD","LU2271345857.HKD","BK4585","LU0203202063.USD","LU1551013425.SGD","IE00BJJMRX11.SGD","LU1280957306.USD","LU0466842654.USD","IE00B4R5TH58.HKD","LU2471134879.HKD","LU0882574055.USD","LU2471134952.CNY","IE0004445015.USD","SG9999015952.SGD","IE00B1BXHZ80.USD","LU0210536198.USD","IE00B1XK9C88.USD","IE00B7KXQ091.USD","LU1691799644.USD","IE00BK4W5M84.HKD","LU0964807845.USD","LU2361044865.SGD","SG9999015986.USD","PJP","SGXZ57979304.SGD","LU1623119135.USD","LU0174119429.USD","LU2106854487.HKD","LU0097036916.USD","LU1917777945.USD","LU0323591593.USD","LU1974910355.USD","LU0256863811.USD","LU0417517546.SGD","LU0823434583.USD","LU2417539215.USD","LU2168564495.EUR","LU0256863902.USD","LU2023250504.SGD","LU1868836591.USD","MEDI","LU0289739699.SGD","LU2237443465.HKD","LU2168564149.EUR","IE0002141913.USD","IE00BJT1NW94.SGD","GDOC","LU0006306889.USD","LU2357305700.SGD","LU2491050071.SGD","LU2361045086.USD","IE0001KFT4U8.USD","LU2461242641.AUD","LU2896262040.SGD","SG9999015945.SGD","LU0354030511.USD","LU2168563687.JPY","LU2468319806.SGD","IE00BWXC8680.SGD","LU1720051017.SGD","ILDR","LU0096364046.USD","IE00BFSS7M15.SGD","SG9999018865.SGD","LU0820562030.AUD","LU0353189763.USD","LU0787776722.HKD","SGXZ51526630.SGD","LU2750360997.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661780652","title":"ANI Pharma Appoints Henry Gosebruch to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2661780652","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661780652?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:55","pubTimestamp":1787568930,"startTime":"0","endTime":"0","summary":"ANI Pharma appoints Henry Gosebruch to board of directorsANI Pharmaceuticals appointed Henry Gosebruch to its board, effective Aug. 19, 2026.Gosebruch has been CEO of Lakefront Biotherapeutics NV sinc","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL5nczHG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BSNM7G36.USD","IYH","BK4585","RXL","MEDX","IE00B2B36J28.USD","JDOC","LU0158827948.USD","LU0211328371.USD","IXJ","LU0417517546.SGD","TRUH","LU0128525929.USD","LU0661504455.SGD","PJP","LU2087621335.USD","IE00BKPKM429.USD","LU0511384066.AUD","LU0689626769.HKD","ANIP","XLV","ABBV","PPH","LU1430594728.SGD","IE00BBT3K403.USD","SG9999014013.SGD","GLAM","BCDF","AGNG","IE000WAW04H5.SGD","LU1989772840.SGD","LU0314104364.USD","VHT","FTXH","LU0738911758.USD","BK4588","LU0395794307.EUR","LU0069063385.USD","LU2089283258.USD","NMRA","FHLC","LU0868494617.USD","LU1670627923.USD","NDAQ","LU1718418525.SGD","IE00BN0W2W23.USD","LU2129689514.USD","LU1037948897.HKD","LU2210150020.SGD","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149972463","title":"Drug Innovation and Computing Hardware Supply Chains Plunge, ChiNext Index Falls Over 3% | 3A Daily Report (August 24, 2026)","url":"https://stock-news.laohu8.com/highlight/detail?id=1149972463","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149972463?lang=en_us&edition=fundamental","pubTime":"2026-08-24 17:50","pubTimestamp":1787565027,"startTime":"0","endTime":"0","summary":"The ChiNext Index dropped more than 3% on Tuesday as steep declines in innovative drug development and computing hardware supply chain stocks weighed heavily on market sentiment. 永泰生物-B...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["399006","399001","LNGR","06978","07234","BK1574","MEDX","03147","IBBQ","159992","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661224498","title":"Barclays Sticks to Its Buy Rating for Eli Lilly & Co (LLY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661224498","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661224498?lang=en_us&edition=fundamental","pubTime":"2026-08-24 16:45","pubTimestamp":1787561121,"startTime":"0","endTime":"0","summary":"Barclays analyst Emily Field maintained a Buy rating on Eli Lilly & Co today and set a price target of $1,400.00. Field covers the Healthcare secto...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-sticks-to-its-buy-rating-for-eli-lilly-co-lly-blurbs-news-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-sticks-to-its-buy-rating-for-eli-lilly-co-lly-blurbs-news-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BJJMRY28.SGD","SG9999015945.SGD","FTXH","LU0316494557.USD","LU2471134952.CNY","LU1868836591.USD","SG9999014906.USD","LU0943347566.SGD","LU0689472784.USD","LU1069344957.HKD","LU2089283258.USD","LU1551013342.USD","LU0823434740.USD","LU2168564222.USD","LU0061475181.USD","IE0002141913.USD","IXJ","RXL","VHT","XLV","IE00BKPKM429.USD","LU2361044865.SGD","LU1035775433.USD","LU1145028129.USD","LU0320765059.SGD","FHLC","AGNG","LU2237443465.HKD","IE0004445239.USD","LU2750360641.GBP","SG9999017495.SGD","LU2552382058.USD","LU0787776722.HKD","LU1629891620.HKD","LU0114720955.EUR","LU0323591593.USD","LU2552382132.HKD","LU2471134523.USD","LU2023250330.USD","LU2237443549.SGD","LU2112291526.USD","LU0106261372.USD","LU0354030511.USD","BK4599","LU2361044949.HKD","LU0006306889.USD","LU0417517546.SGD","IYH","LLYX","LU0820562030.AUD","LU0354030438.USD","LU2023250504.SGD","LU1061106388.HKD","LU1323610961.USD","IE00B4JS1V06.HKD","LU0683600562.USD","LU2023251221.USD","PPH","SGXZ81514606.USD","IE00BN29S564.USD","LU0109394709.USD","LU0122379950.USD","IE00B7KXQ091.USD","LU1366192091.USD","LU2237443622.USD","LU2324357040.USD","LU1804176565.USD","GDOC","LU0079474960.USD","LU2602419157.SGD","LU0889565916.HKD","CANC","LU0820561909.HKD","LU2750360997.AUD","LU2417539215.USD","IE00BJT1NW94.SGD","SG9999001176.USD","LU0203202063.USD","LU0198837287.USD","LU0456855351.SGD","LU2360106947.USD","LU2236285917.USD","LU0174119429.USD","LU1093756325.SGD","THNR","LU2264538146.SGD","LU1232071149.USD","SG9999014898.SGD","LU2491050071.SGD","IE00BFTCPJ56.SGD","HRTS","LU2087625088.SGD","LU0203201768.USD","SGXZ57979304.SGD","LU0345770308.USD","LU1623119135.USD","LU2237438978.USD","IE00B2B36J28.USD","IE00BWXC8680.SGD","LU2462157665.USD","LU2896262040.SGD","LU0238689110.USD","OZEM","LU2456880835.USD","LU0097036916.USD","LU0786609619.USD","LU0432979614.USD","LU1551013425.SGD","LU0058720904.USD","TMED","IE0004445015.USD","LU0234572021.USD","LU0096364046.USD","BK4516","LU2106854487.HKD","SG9999015952.SGD","LU0385154629.USD","LU0471298694.HKD","SGXZ51526630.SGD","LU0158827948.USD","LU0820561818.USD","LU2089284900.SGD","MEDX","LU0289739699.SGD","TRUH","LU1868836914.USD","LU1712237335.SGD","LU1291159041.SGD","LU1720051108.HKD","LU0109391861.USD","LU2471134879.HKD","LU0353189680.USD","SG9999001176.SGD","LU2168564065.EUR","LU1093756168.USD","LU2108987350.USD","LU2237443382.USD","LU1720051017.SGD","LU2357305700.SGD","LU2461242641.AUD","LU0964807845.USD","IE00BJLML261.HKD","IE0001KFT4U8.USD","LU1988902786.USD","LU2168564495.EUR","LU2552382215.SGD","LU2361045086.USD","LU0823434583.USD","LU1868837136.USD","SG9999018865.SGD","ILDR","LU0708995401.HKD","BK4533","LU1983299246.USD","ELIS","BK4581","LLY","LU2213496289.HKD","SG9999014914.USD","LU0640476718.USD","LU0882574139.USD","IE0009355771.USD","LU0466842654.USD","LU1057294990.SGD","LU2746668974.SGD","LU0266013472.USD","LU2756315664.SGD","SGXZ31699556.SGD","IE00BFSS8Q28.SGD","IE00BKDWB100.SGD","IE00B4R5TH58.HKD","LU1064131342.USD","LU1023059063.AUD","LU2089984988.USD","LLII","MHIP","LU2211815571.USD","SG9999014880.SGD","LU2168564149.EUR","LU0094547139.USD","LU0256863811.USD","LU0256863902.USD","LU0133085943.USD","IE00BK4W5M84.HKD","CURE","LU0320765992.SGD","IE00BJJMRX11.SGD","LU0823416689.USD","JDOC","LU2468319806.SGD","LU2063271972.USD","LU1974910355.USD","IHE","SG9999013999.USD","LU2491049909.HKD","LU1868836757.USD","LU0672654240.SGD","LU1691799644.USD","LU0353189763.USD","LU1989771016.USD","IE00B775H168.HKD","LU2168563687.JPY","LU1917777945.USD","SG9999018857.SGD","LU0882574055.USD","IE00BFSS7M15.SGD","LU1267930730.SGD","LU2462591350.SGD","MEDI","IE00B1XK9C88.USD","BK4007","BK4534","BK4585","IE00B1BXHZ80.USD","LU1280957306.USD","ELIL","LU1548497426.USD","LU1868837300.USD","LU2237443895.HKD","LU2111349929.HKD","LU0210536198.USD","WDNA","LU2237443978.SGD","LU2756315318.SGD","LU2746668461.USD","BK4588","LU0345770993.USD","LU0471298777.SGD","SG9999015986.USD","LU2491050154.USD","LU0158827781.USD","LLYZ","PJP","LU1814569148.SGD","IE00BK4W5L77.USD","GB00BDT5M118.USD","SGXZ99366536.SGD","LU2471134796.USD","LU2028103732.USD","SG9999015978.USD","IE0005OL40V9.USD","IE00BJJMRZ35.SGD","LU1127390331.HKD","LU2265009873.SGD","LU0225283273.USD","LU1979441026.SGD","LU2271345857.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184884128","title":"Hong Kong Biotech ETF Offers Full-Chain Access as Drug Developers and CXO Partners Enter Harvest Season","url":"https://stock-news.laohu8.com/highlight/detail?id=1184884128","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184884128?lang=en_us&edition=fundamental","pubTime":"2026-08-24 16:10","pubTimestamp":1787559055,"startTime":"0","endTime":"0","summary":"China's innovative drug industry chain is entering a phase where earnings and international expansion are materializing. According to recent interim reports and earnings previews from listed...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","CXO","IBBQ","159992","06978","WX","MEDX","520970","LNGR","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661226379","title":"Ribomic Completes Site Network for Phase 3 Achondroplasia Trial in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2661226379","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661226379?lang=en_us&edition=fundamental","pubTime":"2026-08-24 14:54","pubTimestamp":1787554445,"startTime":"0","endTime":"0","summary":"The latest update is out from Ribomic, Inc. ( ($JP:4591) ). Ribomic has completed the establishment of all planned clinical trial sites for its Pha...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ribomic-completes-site-network-for-phase-3-achondroplasia-trial-in-japan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ribomic-completes-site-network-for-phase-3-achondroplasia-trial-in-japan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GDOC","MEDX","HYLG","IDNA","NVIB"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":12,"pageCount":2,"totalSize":228,"code":"91000000","status":"200"}]}}